- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0263152

GSL Biotech Private Limited
About GSL Biotech Private Limited
Data last updated:
GSL Biotech Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2016PTC167170. Its GSTIN is 27AAGCG5976N1ZS (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Laxmi Marutrao Bhalke and Ganesh Marutrao Bhalke.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Popular Colony S. No. 45 Warje Malwadi Fl – C3 – 26, Pune, Maharashtra, India – 411052.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.12 Cr, a growth of 51% compared to the previous year. For the same year it recorded a net profit of ₹7.11 Lakh (net margin 6.3%) and EBITDA of ₹10.42 Lakh (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years and 5% over five years.
GSL Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0263152). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of GSL Biotech
Contact details
GSL Biotech Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPopular Colony S. No. 45 Warje Malwadi Fl – C3 – 26, Pune, Maharashtra, India – 411052
- IndustryPharma, Drug Formulation & Development
To see the full contact details of GSL Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of GSL Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of GSL Biotech Private Limited, buy the company report.
Financials of GSL Biotech Private Limited
FY 2024 filings availableGSL Biotech Private Limited reported revenue of ₹1.12 Cr (up 51% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 51% growth in the latest year. EBITDA rose 175% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.11 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | ||||
| Net Profit Margin | 6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of GSL Biotech Private Limited, buy the company report.
Board of directors of GSL Biotech Private Limited
GSL Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Laxmi Marutrao Bhalke | Director | 16 Nov 2016 | 9 Years 11 Months | Current |
| Ganesh Marutrao Bhalke | Director | 16 Nov 2016 | 9 Years 11 Months | Current |
Peer comparison
GSL Biotech Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kadam Pharma Private Limited | ₹1.13 Cr (FY 2025) | -88.0% | Aurangabad, Maharashtra, India | |||
| Index Therapeutics Private Limited | ₹1.13 Cr (FY 2024) | 11.0% | Hyderabad, Telangana, India | |||
| Davabikri Solution Private Limited | ₹1.12 Cr (FY 2025) | -29.0% | Faridabad, Haryana, India | |||
| Ambiens Pharmaceuticals Private Limited | ₹1.12 Cr (FY 2025) | 119.0% | Csa, Uttar Pradesh, India | |||
| GSL Biotech Private Limitedthis company | ₹1.12 Cr (FY 2024) | ₹7.11 Lakh | 6.3% | 51.0% | Pune, Maharashtra, India | |
| Anglo-Indian Pharmaceuticals Private Limited | ₹1.12 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Medicotrans Private Limited | ₹1.12 Cr (FY 2024) | -28.0% | Pune, Maharashtra, India | |||
| Eramedica Private Limited | ₹1.12 Cr (FY 2025) | 64.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of GSL Biotech Private Limited, buy the company report.
Auditor
GSL Biotech Private Limited is audited by GKN&CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GKN&CO. | FY 2023 | 113574W |
Shareholding
The shareholding of GSL Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of GSL Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving GSL Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for GSL Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
GSL Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCG5976N1ZS | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of GSL Biotech Private Limited, buy the company report.
Recent activity
GSL Biotech Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Ganesh Marutrao Bhalke was appointed as Director on 16 Nov 2016.
Frequently asked questions
GSL Biotech is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 November 2016 (10+ years old) and is registered under CIN U51909PN2016PTC167170.
GSL Biotech has 2 current directors:
- Laxmi Marutrao Bhalke - Director
- Ganesh Marutrao Bhalke - Director
The latest financial statements of GSL Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of GSL Biotech is 27AAGCG5976N1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of GSL Biotech is U51909PN2016PTC167170. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GSL Biotech was incorporated on 16 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
The peers of GSL Biotech by revenue are Kadam Pharma Private Limited, Index Therapeutics Private Limited, Davabikri Solution Private Limited, Ambiens Pharmaceuticals Private Limited, Anglo-Indian Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ganesh Marutrao Bhalke was appointed as Director on 16 Nov 2016. Laxmi Marutrao Bhalke was appointed as Director on 16 Nov 2016.
Yes, GSL Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0263152).
The registered office of GSL Biotech is at Popular Colony S. No. 45 Warje Malwadi Fl – C3 – 26, Pune, Maharashtra, India – 411052.
GSL Biotech operates in the pharma industry, in the drug formulation and development segment.